Last viewed:
VTRS
Prices are updated after-hours
VTRS
A
|
$11.25
1.17%
1.16%
4.7M
|
Health Technology
(0.0% 1d)
(-6.3% 1m)
(16.6% 1y)
(1.2% 2d)
(1.4% 3d)
(-0.6% 7d)
(35.09%
volume)
Earnings Calendar: 2023-11-07
Market Cap: $ 13,496,298,750
http://www.viatris.com
Sec
Filling
|
Patents
| 35000 employees
Viatris, Inc. engages in the commercialization and manufacturing of pharmaceutical products. It also offers support services such as diagnostic clinics, educational seminars, and digital tools. The company was founded on February 14, 2019 and is headquartered in Canonsburg, PA.
education
diagnostics
dividends!
add to watch list
Paper trade
email alert is off
Press-releases
Viatris to Report First Quarter 2024 Financial Results on May 9, 2024
Published: 2024-04-16
(Crawled : 21:00)
- prnewswire.com
VTRS
A
|
$11.25
1.17%
1.16%
4.7M
|
Health Technology
| 1.17%
| O: 0.63%
H: 0.54%
C: -0.8%
first
report
financial
results
Emphysema Treatment Market to Reach $8.7 Billion, Globally, by 2032 at 3.3% CAGR: Allied Market Research
Published: 2024-04-16
(Crawled : 14:00)
- prnewswire.com
VTRS
A
|
$11.25
1.17%
1.16%
4.7M
|
Health Technology
| -0.62%
| O: -0.53%
H: 0.0%
C: -1.24%
NVS
|
$94.36
1.93%
0.0%
2.3M
|
Health Technology
| 0.17%
| O: -1.46%
H: 0.0%
C: 0.0%
PHG
|
$19.98
0.0%
540K
|
Health Technology
| -3.34%
| O: -1.21%
H: 0.0%
C: 0.0%
GSK
|
News
|
$39.75
1.22%
0.0%
1.6M
|
Health Technology
| -1.85%
| O: -1.19%
H: 0.52%
C: -0.17%
VRNA
|
$15.82
-1.74%
-1.83%
640K
|
Health Technology
| -0.51%
| O: 1.65%
H: 2.43%
C: 0.87%
reach
treatment
research
market
Viatris Appoints Corinne Le Goff as Chief Commercial Officer
Published: 2024-04-15
(Crawled : 12:00)
- prnewswire.com
VTRS
A
|
$11.25
1.17%
1.16%
4.7M
|
Health Technology
| -0.71%
| O: 0.88%
H: 1.84%
C: -0.96%
commercial
Revance to Present New DAXXIFY® Data at the American Academy of Neurology 2024 Annual Meeting
Published: 2024-04-12
(Crawled : 13:00)
- biospace.com/
VTRS
A
|
$11.25
1.17%
1.16%
4.7M
|
Health Technology
| -2.77%
| O: -0.17%
H: 0.17%
C: -1.9%
RVNC
|
$3.77
-0.53%
-0.53%
1.6M
|
Health Technology
| -15.63%
| O: -2.01%
H: 1.37%
C: -5.92%
daxxify
neurology
meeting
Central Nervous System (CNS) Stimulant Drugs Market size is set to grow by USD 6.48 billion from 2023-2027, Rise in incidence of CNS disorders boost the market, Technavio
Published: 2024-04-10
(Crawled : 09:00)
- prnewswire.com
ALPMF
|
$9.17
43.47%
16K
|
Health Technology
| -9.51%
| O: -100.0%
H: NaN%
C: Infinity%
SNYNF
|
News
|
$92.7
-2.18%
600K
|
Health Technology
| -1.65%
| O: -0.01%
H: 0.0%
C: 0.0%
NVSEF
|
$93.6375
6.88%
82K
|
Health Technology
| -2.16%
| O: -1.67%
H: 0.0%
C: 0.0%
ALPMY
|
$9.47
-1.11%
520K
|
Manufacturing
| -9.26%
| O: -0.29%
H: 0.0%
C: -1.97%
VTRS
A
|
$11.25
1.17%
1.16%
4.7M
|
Health Technology
| -4.01%
| O: -0.6%
H: 1.03%
C: 0.52%
TMO
|
News
|
$544.78
0.6%
0.0%
1.7M
|
Health Technology
| -7.54%
| O: -2.01%
H: 0.0%
C: 0.0%
NVS
|
$94.36
1.93%
0.0%
2.3M
|
Health Technology
| -1.37%
| O: -1.16%
H: 0.0%
C: 0.0%
SNY
|
News
|
$46.32
2.05%
2.01%
3.3M
|
Health Technology
| -2.59%
| O: -0.32%
H: 0.0%
C: 0.0%
JAZZ
|
$109.96
0.63%
0.63%
760K
|
Health Technology
| -4.92%
| O: -1.71%
H: 0.57%
C: 0.37%
disorders
system
set
market
Eczema Therapeutics Market size is set to grow by USD 5.81 bn from 2024-2028,high prevalence of atopic dermatitis boost the market- Technavio
Published: 2024-04-08
(Crawled : 18:00)
- prnewswire.com
SNYNF
|
News
|
$92.7
-2.18%
600K
|
Health Technology
| 0.01%
| O: 2.24%
H: 0.0%
C: -0.8%
AZNCF
|
News
|
$138.24
-4.19%
800
|
Health Technology
| 2.24%
| O: -3.43%
H: 6.21%
C: 6.21%
VTRS
A
|
$11.25
1.17%
1.16%
4.7M
|
Health Technology
| -4.66%
| O: -0.25%
H: 1.1%
C: -0.17%
NVS
|
$94.36
1.93%
0.0%
2.3M
|
Health Technology
| -1.49%
| O: -0.05%
H: 0.43%
C: -0.27%
BMY
|
$48.93
1.3%
0.0%
10M
|
Health Technology
| -4.66%
| O: -0.08%
H: 0.04%
C: -0.35%
BHC
|
$8.69
1.05%
0.0%
2.9M
|
Health Technology
| -16.52%
| O: 0.38%
H: 0.0%
C: -7.27%
ABBV
|
$166.41
1.06%
0.0%
5.5M
|
Health Technology
| -0.9%
| O: 0.77%
H: 1.63%
C: 0.35%
SNY
|
News
|
$46.32
2.05%
2.01%
3.3M
|
Health Technology
| -1.33%
| O: 0.84%
H: 0.0%
C: 0.0%
AZN
|
News
|
$68.56
0.29%
0.29%
4.7M
|
Health Technology
| 1.63%
| O: 0.18%
H: 0.3%
C: 0.19%
eczema
dermatitis
set
therapeutics
market
Contraceptive Market Projected to Reach $119.89 billion by 2030 - Exclusive Report by 360iResearch
Published: 2024-04-03
(Crawled : 02:00)
- prnewswire.com
VTRS
A
|
$11.25
1.17%
1.16%
4.7M
|
Health Technology
| -5.78%
| O: -0.42%
H: 2.78%
C: 1.09%
SNY
|
News
|
$46.32
2.05%
2.01%
3.3M
|
Health Technology
| -2.94%
| O: 0.69%
H: 0.0%
C: 0.0%
report
reach
contraceptive
market
Ocuphire Announces the U.S. Commercial Launch of RYZUMVl™ (Phentolamine Ophthalmic Solution 0.75%) by its Partner Viatris
Published: 2024-04-01
(Crawled : 12:00)
- globenewswire.com
VTRS
A
|
$11.25
1.17%
1.16%
4.7M
|
Health Technology
| -5.22%
| O: 0.84%
H: 0.0%
C: -0.25%
OCUP
|
$1.66
-0.6%
-0.6%
230K
|
Health Technology
| -17.0%
| O: 1.0%
H: 10.4%
C: 10.4%
solution
commercial
ryzumvl
apx3330
Idorsia and Viatris successfully close the transaction for the global research and development collaboration
Published: 2024-03-18
(Crawled : 06:00)
- globenewswire.com
VTRS
A
|
$11.25
1.17%
1.16%
4.7M
|
Health Technology
| -5.78%
| O: -0.59%
H: 0.59%
C: -0.93%
research
global
collaboration
Scott+Scott Attorneys at Law LLP & Hedin Hall LLP Announce Notice of Class Action and Proposed Settlement to All Who Purchased or Acquired Shares of Viatris Inc. Pursuant to a November 2020 Merger of Mylan N.V. and Upjohn, Inc. to Form Viatris
Published: 2024-03-11
(Crawled : 14:00)
- prnewswire.com
VTRS
A
|
$11.25
1.17%
1.16%
4.7M
|
Health Technology
| -8.24%
| O: -0.82%
H: 0.7%
C: -1.56%
acquired
See all
Last 15 days Sec forms
File Id
Form
Published Date
Transaction Date
Direction
Code
Amount Transacted
Owned Amount
0000950170-24-046145
4
2024-04-19
2024-04-18
Buy
A
110162
110162
0000950170-24-046145
4
2024-04-19
2024-04-18
Buy
A
78688
78688
0000950170-24-041927
4
2024-04-04
2024-04-02
Buy
A
18845
18845
0000950170-24-026684
4
2024-03-06
2024-03-04
Buy
A
70085
70085
0000950170-24-026684
4
2024-03-06
2024-03-04
Sell
M
1492
1492
0000950170-24-026684
4
2024-03-06
2024-03-04
Sell
M
17157
17157
0000950170-24-026684
4
2024-03-06
2024-03-03
Sell
M
825
1652
0000950170-24-026684
4
2024-03-06
2024-03-03
Sell
M
16772
33543
0000950170-24-026684
4
2024-03-06
2024-03-02
Sell
M
1727
0
0000950170-24-026684
4
2024-03-06
2024-03-02
Sell
M
13063
0
0000950170-24-026684
4
2024-03-06
2024-03-02
Sell
M
69486
0
0000950170-24-026684
4
2024-03-06
2024-03-02
Buy
A
69486
69486
0000950170-24-026684
4
2024-03-06
2024-03-04
Sell
F
654
157142
0000950170-24-026684
4
2024-03-06
2024-03-04
Buy
M
1493
157796
0000950170-24-026684
4
2024-03-06
2024-03-04
Sell
F
7514
156303
0000950170-24-026684
4
2024-03-06
2024-03-04
Buy
M
17157
163817
0000950170-24-026684
4
2024-03-06
2024-03-03
Sell
F
362
146660
0000950170-24-026684
4
2024-03-06
2024-03-03
Buy
M
826
147022
0000950170-24-026684
4
2024-03-06
2024-03-03
Sell
F
7345
146196
0000950170-24-026684
4
2024-03-06
2024-03-03
Buy
M
16772
153541
0000950170-24-026684
4
2024-03-06
2024-03-02
Sell
F
757
136769
0000950170-24-026684
4
2024-03-06
2024-03-02
Buy
M
1728
137526
0000950170-24-026684
4
2024-03-06
2024-03-02
Sell
F
5721
135798
0000950170-24-026684
4
2024-03-06
2024-03-02
Buy
M
13063
141519
0000950170-24-026684
4
2024-03-06
2024-03-02
Sell
F
30449
128456
0000950170-24-026684
4
2024-03-06
2024-03-02
Buy
M
69486
158905